INS and metabolic dysfunction-associated steatotic liver disease: HFD-induced downregulation of the PPAR signalling pathway specifically in BALB/c is consistent with resistance to NAFLD and suggests that improved insulin sensitivity in this strain can prevent NAFLD whilst promoting increased adiposity.